Pediatrics in Review Note to Institutions for Site Subscriptions
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Prevention of Neisseria meningitidis

Neisseria meningitidis causes approximately 3000 cases of invasive disease annually in the United States. A high rate of nasopharyngeal carriage occurs in household contacts of persons with invasive disease. During an epidemic (a situation that is more common outside of the United States), secondary attack rates in family members may be as high as 4% to 5%. Following a sporadic case of meningococcal disease, the secondary attack rate is approximately 3 per 1000 household members.

Chemoprophylaxis has been very effective in preventing secondary spread of infection, especially if used within 24 h of diagnosing a primary case. Groups that become carriers and should receive chemoprophylaxis are the most likely to have had contact with the oral secretions of a case of invasive meningococcal infection.







HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 1992 by the American Academy of Pediatrics.